Motus GI to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Published
FORT LAUDERDALE, Fla., Aug. 24, 2023 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company focused on improving endoscopic outcomes and experiences, announced today that Mark Pomeranz, President and Chief Executive Officer, will present at the H.C. Wainwright 25^th Annual Global Investment Conference.*H.C. Wainwright 25*^*th** Annual Global Investment Conference*
Presentation Date: Monday, September 11, 2023 at 7:00 AM ET
Meetings: Management is participating in virtual investor meetings on September 11 – 14, 2023
Webcast: https://journey.ct.events/view/d901ec90-604f-458e-8973-a36787a54f8e
A replay of the webcast will be archived on the Events page on the company’s website, www.motusgi.com and will be available for 90 days.*About Motus GI*
Motus GI Holdings, Inc. is a medical technology company, with subsidiaries in the U.S. and Israel, providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions.
For more information, visit www.motusgi.com and connect with the Company on Twitter, LinkedIn and Facebook.
*Investor Contact:*
Troy Williams
LifeSci Advisors
(518) 221-0106
twilliams@lifesciadvisors.com